Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

Inhibitors of Gram-positive Cell Wall Synthesis

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation.

International journal of molecular sciences·2024

Same author

Discovery of Hit Compounds Targeting the P4 Allosteric Site of K-RAS, Identified through Ensemble-Based Virtual Screening.

Journal of chemical information and modeling·2023

Same author

Effect of Trace Metal Ions on the Conformational Stability of the Visual Photoreceptor Rhodopsin.

International journal of molecular sciences·2023

Same author

A Step Forward toward Selective Activation/Inhibition of Bak, a Pro-Apoptotic Member of the Bcl-2 Protein Family: Discovery of New Prospective Allosteric Sites Using Molecular Dynamics.

Journal of chemical information and modeling·2023

Same author

Effects of solvents on the conformational profile of Balaram's peptide: a computational study.

Physical chemistry chemical physics : PCCP·2022

Same author

Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 M<sup>pro</sup> Protease through Virtual Screening.

Journal of chemical information and modeling·2021

Same journal

Correction: Jiménez-Sánchez et al. Antioxidant Enzymes Genetic Variants Associated with Urticaria/Angioedema Induced by Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs. <i>Pharmaceuticals</i> 2026, <i>19</i>, 522.

Pharmaceuticals (Basel, Switzerland)·2026

Same journal

Correction: Zhao et al. Multifunctional Gel Films of Marine Polysaccharides Cross-Linked with Poly-Metal Ions for Wound Healing. <i>Pharmaceuticals</i> 2022, <i>15</i>, 750.

Pharmaceuticals (Basel, Switzerland)·2026

Same journal

Intravenous Immunoglobulin Reveals a Novel Protective Mechanism: Targeting the GBP5-Driven Pyroptosis Axis in Experimental Colitis.

Pharmaceuticals (Basel, Switzerland)·2026

Same journal

Icariin Attenuates Renal Injury in Streptozotocin-Induced Diabetic Rats with and Without Adenine-Induced Chronic Kidney Disease.

Pharmaceuticals (Basel, Switzerland)·2026

Same journal

AI-Assisted Identification of a Putative Allosteric Ligand Targeting the CDK4/Cyclin D1 Protein-Protein Interface.

Pharmaceuticals (Basel, Switzerland)·2026

Same journal

Development and Study of Hydrophilic Ointment Compositions with a Dextrin/Polyvinyl Alcohol/Iodine Complex (D/PVA/I).

Pharmaceuticals (Basel, Switzerland)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

Small Molecule Protease Inhibitors as Model Peptidomimetics.

Patricia Gomez-Gutierrez¹, Juan J Perez¹

¹Departament d'Enginyeria Química, Universitat Politècnica de Catalunya-Barcelona Tech, Edifici ETSEIB, Av. Diagonal 647, 08028 Barcelona, Catalonia, Spain.

Pharmaceuticals (Basel, Switzerland)

|September 27, 2025

Summary

This summary is machine-generated.

Protease inhibitors are crucial for treating diseases like cancer and cardiovascular conditions. This review details their design, from substrate-based strategies to improved drug profiles, highlighting successful therapeutic examples.

Keywords:

drug discovery isostere replacement peptidomimetics protease inhibitors structure–activity relationships

More Related Videos

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Experiment Videos

Last Updated: Jun 19, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Area of Science:

Biochemistry and Molecular Biology
Enzymology
Drug Discovery

Background:

Proteases are vital enzymes regulating physiological processes, with dysregulation linked to diseases like cancer and neurodegenerative disorders.
Protease inhibitors offer therapeutic potential by modulating enzyme activity, complementing control via enzyme concentration.
Small molecule protease inhibitors are developed using substrate-based design and iterative optimization for improved drug-like properties.

Purpose of the Study:

To review the design process of protease inhibitors, from initial substrate-based approaches to optimized second-generation drugs.
To exemplify the inhibitor design process through successful discovery stories of inhibitors targeting diverse protease classes.
To examine challenges in novel protease inhibitor design and their market relevance.

Main Methods:

Review of literature on protease inhibitor design strategies.
Analysis of case studies involving inhibitors for angiotensin converting enzyme, HIV protease, thrombin, and proteasome.
Examination of drug development challenges and market impact.

Main Results:

Successful design of protease inhibitors involves iterative optimization, moving from first-generation substrate mimics to second-generation drugs with improved pharmacokinetic profiles.
Case studies demonstrate effective inhibitor development for metalloproteases, aspartate proteases, serine proteases, and threonine proteases.
Despite successes, challenges remain in designing novel protease inhibitors, yet they hold significant therapeutic and market value.

Conclusions:

Protease inhibitors represent a significant class of therapeutics, with rational design strategies enabling successful drug development.
The iterative optimization of substrate-based inhibitors is key to achieving effective and safe therapeutic agents.
Continued research into protease inhibitor design is essential for addressing unmet medical needs and expanding therapeutic options.